Low LDL Cholesterol and Increased Risk of Type 2 Diabetes

Anthropometry (1)

Biomarkers (3)

Demographics (2)

Disease Events (1)

Race and Ethnicity (1)

Other (11)

  • 250.2 - If the person is a case for phecode 250.2 (TRUE) or a control for the code (FALSE) or an exclusion (NA) (phv00377693.v1.p1)
  • 250.21 - If the person is a case for phecode 250.21 (TRUE) or a control for the code (FALSE) or an exclusion (NA) (phv00377694.v1.p1)
  • 250.22 - If the person is a case for phecode 250.22 (TRUE) or a control for the code (FALSE) or an exclusion (NA) (phv00377695.v1.p1)
  • 250.23 - If the person is a case for phecode 250.23 (TRUE) or a control for the code (FALSE) or an exclusion (NA) (phv00377696.v1.p1)
  • 250.24 - If the person is a case for phecode 250.24 (TRUE) or a control for the code (FALSE) or an exclusion (NA) (phv00377697.v1.p1)
  • 250.25 - If the person is a case for phecode 250.25 (TRUE) or a control for the code (FALSE) or an exclusion (NA) (phv00377698.v1.p1)
  • CONSENT - Consent group as determined by DAC (phv00377686.v1.p1)
  • EHR_length - How long each individual has been in vanderbilt medical system, years (phv00377699.v1.p1)
  • phase - Two phases were included in the study, phase 1 (discover) and phase 2 (replication) (phv00377704.v1.p1)
  • SUBJECT_ID - De-identified Subject ID (phv00377689.v1.p1)
  • SUBJECT_ID - Subject ID (phv00377684.v1.p1)